The global demand for Horseradish Peroxidase Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Horseradish peroxidase is a metalloenzyme found in horseradish roots. It is a single-chain polypeptide containing four disulfide bridges and a glycoprotein containing 18% carbohydrate. Horseradish peroxidase is ideal in many applications because it is smaller, more stable, and less expensive than other popular alternatives. Therefore, it is used extensively in biochemistry applications, most commonly used as an antibody-conjugated enzyme.
Market Dynamics
The global horseradish peroxidase market is mainly driven by research organizations worldwide. The pharmaceutical & biotech industries are spending on research & development of new drugs to address the rise in rare and chronic diseases. For medical diagnostics, it is vital to have a stable and robust biopharmaceutical system to guarantee reliable and reproducible results. Thereby, horseradish peroxidase has become a key component in biopharmaceutical research. In addition, horseradish peroxidase evolved as a biocatalyst in the research field due to its chemical properties. It is widely used in the study of different pharmaceuticals and other fine chemical products. Horseradish peroxidase, when combined with other compounds, is highly reactive toward human tumor cells. Better evidence could lead to new targeted cancer therapy, creating new market opportunities. However, the insignificant drawback of using horseradish peroxidase is that it could result in non-specific staining from the endogenous peroxidase activity observed in specific tissues or cells, hampering the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of horseradish peroxidase. The growth and trends of horseradish peroxidase industry provide a holistic approach to this study.
Market Segmentation
This section of the horseradish peroxidase market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Substrate
By Application
By Grade
- Grade I
- Grade II
- Grade III
By End User
- Biopharmaceutical Companies
- Academic & Research Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Horseradish Peroxidase market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Horseradish Peroxidase Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the horseradish peroxidase market include Abcam plc, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck KGaA, BBI Solutions, Takara Bio Company, Promega Corporation, Faizyme Laboratories, F. Hoffmann-La Roche Ltd., TOYOBO Co., Ltd., Oriental Yeast Co., Ltd. and GenScript. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.